Motor neuron disease in rural Australia: a population-based observational study of epidemiology, clinical characteristics and regional variation
- 1Macquarie University
Abstract
ObjectivesTo characterise the epidemiology, clinical features, and geographic distribution of motor neuron disease (MND) within a rural Australian population.
DesignRetrospective, population-based epidemiology study.
SettingWestern New South Wales Local Health District (WNSWLHD), Australia, from 1 January 2023 to 31 December 2025.
ParticipantsFifty-one individuals diagnosed with MND identified through Central West Neurology and Neurosurgery, Orange Palliative Care Service, and the WNSWLHD Neurodegenerative Community Care Team.
Main outcome measuresCrude and age-standardised incidence, prevalence and mortality rates of MND; demographic and clinical characteristics; geographic distribution of prevalence.
ResultsThe all-age crude incidence of MND was 4.01 per 100,000 person-years (95% CI, 2.78-5.60), prevalence was 8.14 per 100,000 population (95% CI, 6.33-10.30), and mortality was 3.77 per 100,000 person-years (95% CI, 2.58-5.33). Females comprised 51% of patients and showed higher incidence, prevalence and mortality than males. Bulbar-onset MND accounted for 47% of patients, including 61% of females. MND prevalence varied across the health district, with the highest burden observed in central and south-eastern regional areas. Patients travelled on average 139 km to access neurological care, with a diagnostic delay of nine months.
ConclusionsMND incidence and mortality are high in this rural Australian population compared with national and global estimates, with an overrepresentation of bulbar-onset disease and altered sex distribution. These findings provide an important baseline for population-level MND surveillance, following the introduction of mandatory notification in NSW, Australia. Findings also highlight the need for strengthened rural healthcare services, and further research of potential genetic and environmental contributors to MND risk.
Strengths and limitations of this studyO_LIThis population-based study used multiple clinical and health-service data sources across Western New South Wales Local Health District, with records cross-referenced to maximise case ascertainment and remove duplicates. C_LIO_LIThe 2023-2025 study period provides a pre-notification epidemiological baseline preceding the introduction of mandatory motor neuron disease (MND) notification in New South Wales in September 2026. C_LIO_LIEpidemiological and geographical analyses used standardised population denominators and established Australian classifications of remoteness and land use. C_LIO_LIThe relatively small number of people with MND limited statistical precision, particularly for subgroup and Local Government Area-level analyses. C_LIO_LIIndividual-level genetic, occupational and environmental exposure data were unavailable, limiting investigation of factors potentially underlying demographic and geographic variation. C_LI
Related
- Emerging epidemiology of invasive group a Streptococcus in tropical Australia: a 21-year population-based data linkage study
- Prevalence and Clinical Characteristics of Supernumerary Teeth in a Pediatric Clinical Population: A Retrospective Observational Study
- Age, period, and cohort effects in the population-level incidence and mortality of cancer types associated with early onset increases in Australia
- Epidemiology and outcome of sudden cardiac arrest in elderly Nigerians: a prospective multicentre observational survey
- Heart failure in Somalia: a scoping review of the epidemiology, etiology, clinical characteristics, management, outcomes, and evidence gaps
BibTeX
@misc{wright2026motor,
title = {{Motor neuron disease in rural Australia: a population-based observational study of epidemiology, clinical characteristics and regional variation}},
author = {A. L. Wright and Z. N. Zussa and S. Chan Moi Fat and C. M. Y. Lee and L. Christie and C. Keniry and S. Hawke and D. B. Rowe and K. L. Williams and L. Henden},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.08.26362473},
url = {https://www.medrxiv.org/content/10.64898/2026.09.08.26362473v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Motor neuron disease in rural Australia: a population-based observational study of epidemiology, clinical characteristics and regional variation
AU - A. L. Wright
AU - Z. N. Zussa
AU - S. Chan Moi Fat
AU - C. M. Y. Lee
AU - L. Christie
AU - C. Keniry
AU - S. Hawke
AU - D. B. Rowe
AU - K. L. Williams
AU - L. Henden
PY - 2026
DA - 2026/09/08
PB - medRxiv
DO - 10.64898/2026.09.08.26362473
UR - https://www.medrxiv.org/content/10.64898/2026.09.08.26362473v1
AB - ObjectivesTo characterise the epidemiology, clinical features, and geographic distribution of motor neuron disease (MND) within a rural Australian population. DesignRetrospective, population-based epidemiology study. SettingWestern New South Wales Local Health District (WNSWLHD), Australia, from 1 January 2023 to 31 December 2025. ParticipantsFifty-one individuals diagnosed with MND identified through Central West Neurology and Neurosurgery, Orange Palliative Care Service, and the WNSWLHD Neurodegenerative Community Care Team. Main outcome measuresCrude and age-standardised incidence, prevalence and mortality rates of MND; demographic and clinical characteristics; geographic distribution of prevalence. ResultsThe all-age crude incidence of MND was 4.01 per 100,000 person-years (95% CI, 2.78-5.60), prevalence was 8.14 per 100,000 population (95% CI, 6.33-10.30), and mortality was 3.77 per 100,000 person-years (95% CI, 2.58-5.33). Females comprised 51% of patients and showed higher incidence, prevalence and mortality than males. Bulbar-onset MND accounted for 47% of patients, including 61% of females. MND prevalence varied across the health district, with the highest burden observed in central and south-eastern regional areas. Patients travelled on average 139 km to access neurological care, with a diagnostic delay of nine months. ConclusionsMND incidence and mortality are high in this rural Australian population compared with national and global estimates, with an overrepresentation of bulbar-onset disease and altered sex distribution. These findings provide an important baseline for population-level MND surveillance, following the introduction of mandatory notification in NSW, Australia. Findings also highlight the need for strengthened rural healthcare services, and further research of potential genetic and environmental contributors to MND risk. Strengths and limitations of this studyO_LIThis population-based study used multiple clinical and health-service data sources across Western New South Wales Local Health District, with records cross-referenced to maximise case ascertainment and remove duplicates. C_LIO_LIThe 2023-2025 study period provides a pre-notification epidemiological baseline preceding the introduction of mandatory motor neuron disease (MND) notification in New South Wales in September 2026. C_LIO_LIEpidemiological and geographical analyses used standardised population denominators and established Australian classifications of remoteness and land use. C_LIO_LIThe relatively small number of people with MND limited statistical precision, particularly for subgroup and Local Government Area-level analyses. C_LIO_LIIndividual-level genetic, occupational and environmental exposure data were unavailable, limiting investigation of factors potentially underlying demographic and geographic variation. C_LI
ER -